Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rhett Hallows

Orthopaedic Surgery Raleigh, NC Medical Doctor

NPI 1043498553 CMS profile 735056

7850 Brier Creek Pkwy Ste 200, Raleigh, NC 27617

Open in the dashboard

General payments

$388,015

335 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rhett Hallows of Raleigh, NC is reported in the CMS Open Payments database as having received $388,015 across 335 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $25,770 28
2024 General $80,235 70
2023 General $48,889 53
2022 General $129,868 85
2021 General $62,935 51
2020 General $18,046 8
2019 General $22,271 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rhett Hallows
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Rhett Hallows were reported at $25,770. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Rhett Hallows Orthopaedic Surgery median Middle half National median
2019 $22,271 $644 $140–$2,844 $163
2020 $18,046 $312 $75–$1,860 $114
2021 $62,935 $520 $117–$2,495 $132
2022 $129,868 $598 $128–$2,731 $149
2023 $48,889 $461 $128–$2,264 $160
2024 $80,235 $497 $134–$2,475 $164
2025 $25,770 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $377,454 277 payments
  2. Total Joint Orthopedics, Inc. $9,102 29 payments
  3. Zimmer Biomet Holdings, Inc. $1,355 22 payments
  4. Heraeus Medical, LLC. $19 1 payment
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $18 1 payment
  6. Flexion Therapeutics, Inc. $17 1 payment
  7. Next Science LLC $15 1 payment
  8. Janssen Pharmaceuticals, Inc $13 1 payment
  9. Zyla Life Sciences $12 1 payment
  10. DePuy Synthes Sales Inc. $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $212,986 51 payments
  2. Consulting Fee $111,863 37 payments
  3. Travel and Lodging $50,132 95 payments
  4. Food and Beverage $10,353 138 payments
  5. Royalty or License $2,682 14 payments
Products named General payments · program years 2019–2025
  1. REAL INTELLIGENCE $155,642 107 payments
  2. JOURNEY II Recon Knees $137,729 71 payments
  3. POLARSTEM $108,462 45 payments
  4. TANDEM $86,860 58 payments
  5. LEGION Revision $74,915 44 payments
  6. POLARCUP $68,461 17 payments
  7. JOURNEY II Recon Knees $66,294 17 payments
  8. JOURNEY II Recon Knees $49,325 18 payments
  9. REDAPT $44,450 19 payments
  10. OR3O Dual Mobility $42,444 30 payments
  11. Other $462,998 388 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

412

Median for Orthopedic Surgery: 203

Drug cost

$3,334

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 59 $1,615
Oxycodone Hcl Generic 87 $560
Meloxicam Generic 83 $323
Prednisone Generic 16 $270
Gabapentin Generic 59 $244
Hydromorphone Hcl Generic 11 $81
Tramadol Hcl Generic 24 $69
Ondansetron Hcl Generic 12 $68
Methylprednisolone Generic 14 $56
Amoxicillin Generic 35 $35

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$144,274

Of which drugs: $1,429

Medicare patients

372

Average age 74

Services billed

1,743

221 women, 151 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Depression 23%
Diabetes 21%
Ischemic heart disease 19%
Chronic kidney disease 17%
Osteoporosis 16%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 50 504 $383

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

335 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record